STOCK TITAN

ARGAN INC SEC Filings

AGX NYSE

Welcome to our dedicated page for ARGAN SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Argan, Inc. SEC filings document the company’s operating results, material events and governance as a NYSE-listed construction services issuer. Recent 8-K filings report quarterly and fiscal financial results, cash dividends, share repurchase program actions, and engineering, procurement and construction contract developments involving Gemma Power Systems and power-generation projects.

Proxy materials cover board elections, executive compensation, equity awards, shareholder voting matters and related governance disclosures. The filings also identify Argan’s common stock registration and formal event reporting for capital allocation and project-backlog developments.

Rhea-AI Summary

ARGAN INC director Jeffrey John Ronald Jr. reported compensation-related equity activity and updated holdings. On June 10, 2026, he exercised derivative awards to acquire 533 shares of common stock at $0.00 per share, bringing his direct common stock holdings to 2,533 shares.

On the same date, 530 Time-Based Restricted Stock Units (TRSUs) vested and became issuable as common stock under a one-year vesting schedule, and he received a new grant of 189 TRSUs that will fully vest on June 10, 2027 or at the 2027 Annual Meeting, whichever occurs first. He also reports 8,000 shares of common stock held indirectly through a John R. Jeffrey IRA. No open-market purchases or sales were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

QUINN JAMES W reported acquisition or exercise transactions in this Form 4 filing.

ARGAN INC director James W. Quinn reported equity compensation-related transactions with no open-market buying or selling. On June 10, 2026, 530 shares of common stock became issuable to him as earlier-awarded Time-Based Restricted Stock Units vested, increasing his directly held common stock to 15,580 shares.

On the same date, he received a new grant of 189 Time-Based Restricted Stock Units, which will vest fully on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever comes first. Following these transactions, he also indirectly holds 36,223 common shares through the James W. Quinn 2025 GRAT No.1 and directly holds 1,023 Time-Based Restricted Stock Units.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Getsinger Peter W reported acquisition or exercise transactions in this Form 4 filing.

ARGAN INC director Peter W. Getsinger reported equity compensation activity involving the company’s common stock and restricted stock units. On June 10, 2026, 530 shares of common stock became issuable to him as Time-Based Restricted Stock Units (TRSUs) vested under a one-year vesting schedule.

On the same date, he was granted new TRSUs covering 189 shares of common stock, which will fully vest on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever occurs first. Following these transactions, he holds 6,880 shares of common stock directly, plus small indirect holdings in a custody account for a child and a children’s trust, and 1,023 TRSUs directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

ARGAN INC director Alexander Lisa Larroque reported equity compensation activity, not open-market trading. On June 10, 2026, she exercised previously granted Time-Based Restricted Stock Units, receiving 533 shares of common stock at a reported price of $0.00 per share, bringing her direct common stock holdings to 883 shares.

On the same date, she was also granted 189 Time-Based Restricted Stock Units, each representing a right to receive one share of common stock. According to the vesting terms, these TRSUs will fully vest on June 10, 2027 or on the date of the 2027 Annual Meeting of Stockholders, whichever occurs first.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Argan, Inc. reported the results of its 2026 Annual Meeting and confirmed that three matters were resolved by stockholder vote, including the election of directors and related proposals shown in detailed vote counts.

The Board also declared a regular quarterly cash dividend of $0.50 per share on common stock, payable on July 31, 2026 to stockholders of record at the close of business on July 23, 2026. The company emphasized that continuing this dividend recognizes long-term shareholder support and is positioned against what management describes as strong demand for its power and infrastructure construction services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.9%
Tags
current report
-
Rhea-AI Summary

Argan, Inc. (AGX) delivered a very strong quarter. For the three months ended April 30, 2026, revenues were $290.9 million, up 50.2% from $193.7 million, driven by major power projects in Texas, the Midwest and Ireland plus nearly doubled Industrial activity.

Profitability improved sharply. Net income rose to $46.1 million from $22.6 million, with diluted EPS increasing to $3.24 from $1.60. Gross margin expanded to about 21% as project mix and execution improved, particularly on Midwest solar and battery work, while SG&A grew more slowly than revenue.

The balance sheet remains very strong. Cash and cash equivalents were $355.8 million, with total investments of $617.7 million and no borrowings under the $35 million credit facility. Remaining unsatisfied performance obligations were about $2.8 billion, largely in the Power segment, supporting multi‑year revenue visibility.

The board maintained a shareholder-return focus, paying a $0.50 per share cash dividend and expanding the share repurchase authorization to $200 million, under which 6,450 shares were bought for approximately $3.0 million in the quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
quarterly report
-
Rhea-AI Summary

Argan, Inc. reported a strong first quarter of fiscal 2027, delivering record revenue of $290.9 million, up 50.2% from the prior-year period. All operating segments contributed to the growth, led by increased construction activity in the Power segment.

Gross profit rose to $61.1 million with a gross margin of 21.0%, up from 19.0%. Net income more than doubled to $46.1 million, driving diluted earnings per share of $3.24 versus $1.60 a year earlier. Adjusted EBITDA increased to $56.4 million, reflecting a margin of 19.4%.

Argan ended April 30, 2026 with cash, cash equivalents and investments totaling $973.6 million, net liquidity of $421.4 million and no debt. Project backlog was approximately $2.8 billion, providing multi-year revenue visibility as the company invests in a new fabrication facility to support industrial and data center demand.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
current report
Rhea-AI Summary

ARGAN INC director Peter W. Getsinger reported multiple share movements involving the company’s common stock. On April 29, 2026, he sold 3,000 shares in an open‑market transaction at an average price of $628.36 per share, leaving 6,847 shares held directly after this sale.

On the same date, he also made a bona fide gift of 500 shares of common stock. In addition to his direct holdings, he reports indirect ownership of 133 shares held in a custody account for a child and 267 shares held in a children's trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many ARGAN (AGX) SEC filings are available on StockTitan?

StockTitan tracks 145 SEC filings for ARGAN (AGX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ARGAN (AGX)?

The most recent SEC filing for ARGAN (AGX) was filed on June 12, 2026.